LCLaura Carot

Laura Carot

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laura Carot has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Xavier Bessa

    Gastroenterology Department, Hospital del Mar, Barcelona, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

    4 shared publications
  • Cristina Hernández

    Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain

    3 shared publications
  • Agnés Raga

    Endoscopy Unit, Department of Digestive Diseases, Hospital del Mar, Barcelona, Spain

    2 shared publications
  • Andrea Buron

    Epidemiology and Evaluation Research group,Hospital del Mar Research Institute, Barcelona, Spain; Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; Research Network on Chronicity, Primary Care and Prevention and Health Promotion (RICAPPS), Madrid, Spain

    2 shared publications
  • Cristina Álvarez-Urturi

    2 shared publications
  • Francesc Macià

    Department of Epidemiology Hospital del Mar Research Institute Barcelona Spain

    2 shared publications

Latest Publications

  • Open Access

    Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial

    by Laura Carot, Antoni Castells, Cristina Hernández, Cristina Alvarez-Urturi, Francesc Balaguer, Angel Lanas, Joaquín Cubiella, Jose D Tasende, Rodrigo Jover, Vicent Hernandez, et al.

    Background: The diagnostic yield of the faecal immunochemical test and sigmoidoscopy in detecting proximal serrated polyps in a colorectal cancer screening programme has not been fully assessed.Aim: We determined the detection rate of proximal serrated polyps by simulated sigmoidoscopy and faecal immunochemical test compared with total colonoscopy in a population‐based, multicentre, nationwide, randomised controlled trial (ColonPrev study).Methods: Sigmoidoscopy yield was simulated based on the UK‐Flexible Sigmoidoscopy Trial for total colonoscopy referral. Definitions were: proximal serrated polyp (proximal serrated polyp): sessile serrated polyp or hyperplastic polyp of any size and proximal at‐risk serrated polyp (at‐risk proximal serrated polyp): sessile serrated polyp of any size or hyperplastic polyp ≥ 10 mm, both located proximally to the splenic flexure.Results: A total of 10,611 individuals underwent faecal immunochemical test and 5059 underwent total colonoscopy and were evaluated by simulated sigmoidoscopy. Sigmoidoscopy and faecal immunochemical test were less accurate in detecting proximal serrated polyps (odds ratio: 0.13; 95% confidence interval: 0.10–0.18 and 0.13; 0.09–0.18, p < 0.0001, respectively). Both tests were inferior to colonoscopy in detecting at‐risk proximal serrated polyps, and sigmoidoscopy was inferior to faecal immunochemical test in detecting these lesions (odds ratio: 0.17; 95% confidence interval: 0.10–0.30 and 0.25; 0.17–0.37, p < 0.0001, respectively).Conclusion: Sigmoidoscopy and faecal immunochemical test are less accurate in detecting proximal serrated polyps than colonoscopy, particularly in women.


  • Cápsula endoscópica en patología digestiva

    by Laura Carot, Agnès Fernández, Diana Zaffalon, Josep Maria Dedeu, Xavier Bessa

  • Open Access

    Efficacy of a multifactorial strategy for bowel preparation in diabetic patients undergoing colonoscopy: a randomized trial

    by Marco Antonio Alvarez-Gonzalez, Juana A. Flores-Le Roux, Agustin Seoane, Juan Pedro-Botet, Laura Carot, Agnés Fernandez-Clotet, Agnés Raga, Miguel A. Pantaleon, Luis Barranco, Felipe Bory, et al.

    Background and study aims: Previous studies have reported that diabetes mellitus is an independent risk factor for inadequate bowel preparation. Current guidelines do not recommend a specific preparation for this patient population. The aims of this study were to assess the efficacy, safety, and tolerability of an adapted preparation protocol for colon cleansing in patients with type 2 diabetes mellitus. Patients and methods: This randomized, single-blind, parallel group, superiority trial compared a conventional bowel preparation protocol (CBP) with a diabetes-specific preparation protocol (DSP). The CBP included a low-fiber diet for 3 days followed by a clear liquid diet for 24 hours before colonoscopy. The DSP included a multifactorial strategy combining an educational intervention, a low-fiber diet, and adjustment of blood glucose-lowering agents. All patients received 4 L of a polyethylene glycol solution in a split-dose regimen. The endoscopists were blinded to the preparation protocol. The primary outcome measure was inadequate bowel preparation according to the Boston Bowel Preparation Scale. Secondary outcome measures included hypoglycemic events, tolerability, and acceptability. Results: A total of 150 patients were included in the study (74 CBP and 76 DSP). Both groups were comparable in terms of baseline characteristics. Inadequate bowel cleansing was more frequent following CBP than DSP (20 % vs. 7 %, P = 0.014; risk ratio 3.1, 95 % confidence interval 1.2 – 8). Only CBP and performance status were independently associated with inadequate bowel preparation. Both preparations were equally tolerated and accepted by patients, and side-effects were similar between the groups. Conclusions: A multifactorial strategy for bowel preparation in patients with diabetes undergoing colonoscopy showed a threefold reduction in the rate of inadequate bowel preparation, with no differences in safety and tolerability compared with conventional preparation. Trial registration: ClinicalTrials.gov (NCT02300779).


  • Mo1687 A Trend Towards Proximal Advanced Neoplasia Detection on Consecutive Rounds in a Population Colorectal Cancer (CRC) Screening Program. Preliminary Results of a Third Round

    by Laura Carot, Cristina Hernández, Cristina Álvarez-Urturi, Josep M Augé, Andrea Buron, Francesc Macià, Antoni Castells, Montserrat Andreu, Xavier Bessa

  • Mo1686 Impact of Additional Colonoscopies in a Population Colorectal Cancer (CRC) Screening Program. Improvement Strategies

    by Laura Carot, Agnés Raga, Cristina Hernández, Andrea Buron, Merce Comas, Francesc Macià, Cristina Álvarez-Urturi, Montserrat Andreu, Xavier Bessa